China Veterinary Intravenous Solution Market Size & Outlook, 2026-2034
China Veterinary Intravenous Solution Market Insights
- According to Reed Intelligence analysis, the China Veterinary Intravenous Solution Market size was USD 198.56 Million in 2025 and is projected to reach USD 420.93 Million by 2034.
- The China market is projected to grow at a CAGR of 8.68% between 2026 and 2034.
- By segment, Isotonic Crystalloid Solutions emerged as the largest Product Type in terms of market size in 2025.
- Hypertonic Solutions is anticipated to remain the most attractive Product Type segment, recording the fastest growth during the forecast period.
![China Veterinary Intravenous Solution Market Size, Share & Growth Analysis By [2034]](https://reedintelligence.com/uploads/charts/china-veterinary-intravenous-solution-market-china-product-type-208177.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, China held 13.98% of the global Veterinary Intravenous Solution Market size.
- By 2034, United States is anticipated to capture the largest share of the global Veterinary Intravenous Solution Market.
- In Asia Pacific, China is expected to lead the regional Veterinary Intravenous Solution Market size by 2034.
- South Korea will remain the fastest-growing market in Asia Pacific, reaching USD 59.34 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 198.56 Million |
| Market Size In 2034 | USD 420.93 Million |
| Largest segment | Isotonic Crystalloid Solutions |
| Units | Revenue in USD Million |
| CAGR | 8.68% (2026-2034) |
| Segmnetation Covered | |
| Product Type |
|
| Animal Type |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Veterinary Intravenous Solution Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isotonic Crystalloid Solutions | XX.x | XX.x | XX.x | 69.52 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hypertonic Solutions | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Colloid Solutions | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Parenteral Nutrition Solutions | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Blood and Plasma Products | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Veterinary Intravenous Solution Market Animal Type 2026-2034 (USD Million)
| Animal Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Companion Animals | XX.x | XX.x | XX.x | 79.48 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Livestock Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Equine Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Exotic Animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Veterinary Intravenous Solution Market End Use 2026-2034 (USD Million)
| End Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals | XX.x | XX.x | XX.x | 83.42 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Homecare and Mobile Veterinary Services | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Research and Academic Institutes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.